Vimarsana
Biggest News Aggregation in the World

Torno Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Torno Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Torno Capital Today - Breaking & Trending Today

Pilgrim's Pride Co. (NASDAQ:PPC) Receives $32.00 Average Target Price from Brokerages - Vimarsana News

Pilgrim's Pride Co. (NASDAQ:PPC) Receives $32.00 Average Target Price from Brokerages

Pilgrim’s Pride Co. (NASDAQ:PPC – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the four analysts that are covering the company, Marketbeat reports. One analyst has rated the stock with a hold rating and three have issued a buy rating on the company. The average twelve-month price objective among brokerages […]

Innoviz Technologies' (INVZ) "Overweight" Rating Reiterated at JPMorgan Chase & Co. - Vimarsana News

Innoviz Technologies' (INVZ) "Overweight" Rating Reiterated at JPMorgan Chase & Co.

Innoviz Technologies (NASDAQ:INVZ – Get Free Report)‘s stock had its “overweight” rating reaffirmed by stock analysts at JPMorgan Chase & Co. in a report issued on Tuesday, Benzinga reports. They currently have a $7.00 price objective on the stock, down from their previous price objective of $13.00. JPMorgan Chase & Co.‘s target price indicates a […]

Brokerages Set indie Semiconductor, Inc. (NASDAQ:INDI) PT at $13.50 - Vimarsana News

Brokerages Set indie Semiconductor, Inc. (NASDAQ:INDI) PT at $13.50

Indie Semiconductor, Inc. (NASDAQ:INDI – Get Free Report) has received an average recommendation of “Buy” from the seven ratings firms that are currently covering the firm, MarketBeat Ratings reports. Seven equities research analysts have rated the stock with a buy rating. The average twelve-month price target among analysts that have issued a report on the […]

Zacks Research Analysts Decrease Earnings Estimates for Pacira BioSciences, Inc. (NASDAQ:PCRX) - Vimarsana News

Zacks Research Analysts Decrease Earnings Estimates for Pacira BioSciences, Inc. (NASDAQ:PCRX)

Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) – Research analysts at Zacks Research reduced their Q1 2025 EPS estimates for shares of Pacira BioSciences in a research note issued to investors on Friday, February 23rd. Zacks Research analyst R. Department now anticipates that the company will post earnings per share of $0.69 for the quarter, […]

Q3 2024 EPS Estimates for Pacira BioSciences, Inc. (NASDAQ:PCRX) Reduced by Analyst - Vimarsana News

Q3 2024 EPS Estimates for Pacira BioSciences, Inc. (NASDAQ:PCRX) Reduced by Analyst

Pacira BioSciences, Inc. (NASDAQ:PCRX – Free Report) – Equities research analysts at Zacks Research decreased their Q3 2024 earnings per share estimates for Pacira BioSciences in a note issued to investors on Wednesday, February 21st. Zacks Research analyst R. Department now expects that the company will post earnings per share of $0.59 for the quarter, […]